Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · IEX Real-Time Price · USD
22.01
-0.59 (-2.61%)
At close: Jul 19, 2024, 4:00 PM
21.90
-0.11 (-0.50%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Enliven Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for ELVN stock have an average target of 33, with a low estimate of 32 and a high estimate of 34. The average target predicts an increase of 49.93% from the current stock price of 22.01.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 11, 2024.
Analyst Ratings
The average analyst rating for ELVN stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Initiates $32 | Buy | Initiates | $32 | +45.39% | Jun 11, 2024 |
| Mizuho | Mizuho | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | +54.48% | Apr 9, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +22.67% | Mar 29, 2023 |
| TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 3, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
12.75K
EPS This Year
-2.36
from -2.01
EPS Next Year
-2.92
from -2.36
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | 52,500 | 52,500 |
| Avg | n/a | 12,750 | 12,750 |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | 311.8% |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -2.30 | -2.52 | -3.01 |
| Avg | -2.36 | -2.92 | -3.41 |
| Low | -2.44 | -3.33 | -3.94 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.